Yes, we will start seeing more volume in the coming weeks . . . it's inevitable. Spotlight will continue to grow on the biotech sector with the CLSN, ACAD, "overweight" fund manager ratings for the sector.... not too many other sector have the growth potential . . . maybe biotech the new "high tech" sector for the coming years?